Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye Syndrome Sep 28, 2020
Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020 Jul 30, 2020
Aurinia Announces U.S. Food and Drug Administration Acceptance of the Filing of New Drug Application and Priority Review for Voclosporin for the Treatment of Lupus Nephritis Jul 21, 2020
